Furthermore, GSR and GPX genes have already been reported as essential features to block EMT in melanoma cells, cervical cancer, hepatocellular carcinoma, gastric, pancreatic, breast, and colon cancers (23–26, 30, 42, 43). Here, GSR is linked to malignant colon neoplasm.